Public Radio For Eastern North Carolina 89.3 WTEB New Bern 88.5 WZNB New Bern 91.5 WBJD Atlantic Beach 90.3 WKNS Kinston 88.5 WHYC Swan Quarter 89.9 W210CF Greenville
US

FDA Expected To Approve Esketamine Nasal Spray For Depression

By Jon Hamilton
Published March 4, 2019 at 7:41 PM EST
  • Facebook
  • Twitter
  • LinkedIn
  • Email

Your browser doesn’t support HTML5 audio

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

US
  • Facebook
  • Twitter
  • LinkedIn
  • Email
Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
See stories by Jon Hamilton